SpectraCure (Sweden) Analysis
| SPEC Stock | SEK 0.10 0 3.09% |
SpectraCure's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. SpectraCure's financial risk is the risk to SpectraCure stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that SpectraCure's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which SpectraCure is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of SpectraCure to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, SpectraCure is said to be less leveraged. If creditors hold a majority of SpectraCure's assets, the Company is said to be highly leveraged.
SpectraCure AB is fairly valued with Real Value of 0.097 and Hype Value of 0.1. The main objective of SpectraCure stock analysis is to determine its intrinsic value, which is an estimate of what SpectraCure AB is worth, separate from its market price. There are two main types of SpectraCure's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect SpectraCure's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of SpectraCure's stock to identify patterns and trends that may indicate its future price movements.
The SpectraCure stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. SpectraCure is usually not traded on Ascension Day, NationalDay, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Eve, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday, May Day. SpectraCure Stock trading window is adjusted to Europe/Stockholm timezone.
SpectraCure |
SpectraCure Stock Analysis Notes
About 21.0% of the company outstanding shares are owned by corporate insiders. The book value of SpectraCure was at this time reported as 1.61. The company recorded a loss per share of 0.26. SpectraCure AB had not issued any dividends in recent years. To find out more about SpectraCure AB contact the company at 46 46 16 20 70 or learn more at https://www.spectracure.com.SpectraCure AB Investment Alerts
| SpectraCure AB generated a negative expected return over the last 90 days | |
| SpectraCure AB has high historical volatility and very poor performance | |
| SpectraCure AB has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 5.75 M. Net Loss for the year was (23.34 M) with profit before overhead, payroll, taxes, and interest of 2.99 M. | |
| SpectraCure AB has accumulated about 129.69 M in cash with (18.6 M) of positive cash flow from operations. | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders |
SpectraCure Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 565.68 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate SpectraCure's market, we take the total number of its shares issued and multiply it by SpectraCure's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 17th of February 2026, SpectraCure has the Risk Adjusted Performance of (0.12), coefficient of variation of (612.90), and Variance of 38.3. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of SpectraCure AB, as well as the relationship between them.SpectraCure AB Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. SpectraCure middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for SpectraCure AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
SpectraCure Outstanding Bonds
SpectraCure issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. SpectraCure AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most SpectraCure bonds can be classified according to their maturity, which is the date when SpectraCure AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
SpectraCure Predictive Daily Indicators
SpectraCure intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of SpectraCure stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 86689.22 | |||
| Daily Balance Of Power | 0.1786 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 0.1 | |||
| Day Typical Price | 0.1 | |||
| Price Action Indicator | (0.0001) | |||
| Period Momentum Indicator | 0.003 |
SpectraCure Forecast Models
SpectraCure's time-series forecasting models are one of many SpectraCure's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary SpectraCure's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.SpectraCure AB Debt to Cash Allocation
SpectraCure AB has accumulated 2.49 M in total debt. Debt can assist SpectraCure until it has trouble settling it off, either with new capital or with free cash flow. So, SpectraCure's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like SpectraCure AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for SpectraCure to invest in growth at high rates of return. When we think about SpectraCure's use of debt, we should always consider it together with cash and equity.SpectraCure Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the SpectraCure's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of SpectraCure, which in turn will lower the firm's financial flexibility.SpectraCure Corporate Bonds Issued
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding SpectraCure to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Additional Tools for SpectraCure Stock Analysis
When running SpectraCure's price analysis, check to measure SpectraCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpectraCure is operating at the current time. Most of SpectraCure's value examination focuses on studying past and present price action to predict the probability of SpectraCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpectraCure's price. Additionally, you may evaluate how the addition of SpectraCure to your portfolios can decrease your overall portfolio volatility.